Gritstone Bio Inc (GRTS)
0.573
-0.01
(-1.21%)
USD |
NASDAQ |
Jul 02, 16:00
0.573
0.00 (0.00%)
After-Hours: 05:43
Gritstone Bio SG&A Expense (TTM): 30.54M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 30.54M |
December 31, 2023 | 28.78M |
September 30, 2023 | 27.63M |
June 30, 2023 | 26.68M |
March 31, 2023 | 27.76M |
December 31, 2022 | 28.97M |
September 30, 2022 | 28.89M |
June 30, 2022 | 28.80M |
March 31, 2022 | 26.95M |
December 31, 2021 | 25.93M |
September 30, 2021 | 24.91M |
June 30, 2021 | 23.57M |
Date | Value |
---|---|
March 31, 2021 | 22.89M |
December 31, 2020 | 21.41M |
September 30, 2020 | 21.37M |
June 30, 2020 | 20.92M |
March 31, 2020 | 20.50M |
December 31, 2019 | 19.41M |
September 30, 2019 | 17.66M |
June 30, 2019 | 16.17M |
March 31, 2019 | 14.14M |
December 31, 2018 | 11.81M |
September 30, 2018 | 9.768M |
June 30, 2018 | 8.084M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
17.66M
Minimum
Sep 2019
30.54M
Maximum
Mar 2024
24.92M
Average
25.93M
Median
Dec 2021
SG&A Expense (TTM) Benchmarks
Marinus Pharmaceuticals Inc | 64.57M |
Petros Pharmaceuticals Inc | 9.842M |
NovaBay Pharmaceuticals Inc | 12.53M |
Palatin Technologies Inc | 13.34M |
iBio Inc | 11.84M |